Table 2.
Distribution of Genotypes According to Stage of Controls, Total Patients, and Patient Subgroups
| Genotypes | |||||||
|---|---|---|---|---|---|---|---|
| 4G/4G | 4G/5G | 5G/5G | |||||
| n | n | % | n | % | n | % | |
| Controls | 132 | 28 | 21.2 | 22 | 16.7 | 82 | 62.1 |
| Total patients | 154 | 49 | 31.4 | 48 | 30.8 | 59 | 37.8 |
| Statistics | χ2=17.256 p<0.01a | ||||||
| Nonsmall cell lung cancer | |||||||
| Squamous | |||||||
| Stage 4 | 29 | 12 | 41.4 | 12 | 41.4 | 5 | 17.2 |
| Stage 3B | 19 | 4 | 21.1 | 8 | 42.1 | 7 | 36.8 |
| Stage 3A | 27 | 9 | 33.3 | 10 | 37.0 | 8 | 29.6 |
| Stage 2 | 6 | 2 | 33.3 | 2 | 33.3 | 2 | 33.3 |
| Adenocarcinoma | |||||||
| Stage 4 | 7 | 4 | 57.1 | 1 | 14.3 | 2 | 28.6 |
| Stage 3B | 21 | 3 | 14.3 | 5 | 23.8 | 13 | 61.9 |
| Stage 3A | 8 | 2 | 25.0 | 3 | 37.5 | 3 | 37.5 |
| Stage 2 | 7 | 1 | 14.3 | 0 | 0 | 6 | 85.7 |
| Small cell lung cancer | |||||||
| Stage 4 | 15 | 7 | 46.66 | 2 | 13.33 | 6 | 40 |
| Stage 3B | 9 | 2 | 33.33 | 1 | 16.66 | 3 | 50 |
| Stage 3A | 6 | 3 | 33.33 | 3 | 33.33 | 3 | 33.33 |
| Stage 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
p: χ2 test.